Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gynecological YangXue granule (Fuke Yangxue Keli) is a Traditional Chinese Medicine (TCM) hospital preparation developed by the Guangdong Provincial Hospital of Chinese Medicine. It is a multi-herb formulation traditionally used to treat menstrual disorders such as menostaxis (prolonged or irregular menstruation) and dysmenorrhea by 'nourishing blood and regulating menstruation.' In recent clinical practice and research, it has been specifically utilized to manage cesarean scar diverticulum (CSD), also known as cesarean scar syndrome. The granule is thought to promote the healing of the uterine diverticulum, reduce abnormal uterine bleeding, and regulate the menstrual cycle through its effects on the endocrine system and local blood flow. It is typically administered orally as a dissolved granule and is a key component of the hospital's specialized gynecological treatments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gynecological yangxue granule.